Free Trial
NASDAQ:AIFF

Firefly Neuroscience Q3 2026 Earnings Results & Report

Firefly Neuroscience logo
$0.96 +0.01 (+0.99%)
As of 02:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Firefly Neuroscience reported Q3 2026 earnings on November 10, 2026. The company reported EPS of -$0.07, while revenue was $647 thousand.

Earnings Announcement Details

Quarter
Q3 2026
Time
Before Market Opens

Firefly Neuroscience EPS Results

Actual EPS
-$0.07
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Firefly Neuroscience Revenue Results

Actual Revenue
$647 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Firefly Neuroscience Q3 2026 Earnings FAQ

Firefly Neuroscience (NASDAQ:AIFF) reported earnings of -$0.07 per share for Q3 2026. The report was announced on Tuesday, November 10, 2026.

Firefly Neuroscience reported revenue of $647 thousand for Q3 2026.

Firefly Neuroscience Earnings Headlines

Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.tc pixel
Firefly Hikes on Partnering with NeuroSigma
See More Firefly Neuroscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Firefly Neuroscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Firefly Neuroscience and other key companies, straight to your email.

About Firefly Neuroscience

Firefly Neuroscience (NASDAQ:AIFF) is a digital health and neuroscience company focused on using artificial intelligence to support the assessment and treatment of brain disorders. The company develops technology designed to analyze electroencephalography (EEG) data and identify patterns associated with cognitive and psychiatric conditions.

Its principal platform, Brain Network Analytics (BNA), is intended to convert EEG recordings into clinically relevant measures of brain function. Firefly’s technology is designed to help healthcare professionals evaluate conditions such as Alzheimer’s disease and major depressive disorder, monitor changes in patients’ brain activity, and support more personalized treatment decisions.

Firefly Neuroscience became a publicly traded company on Nasdaq under the symbol AIFF following a business combination with WaveDancer, Inc. in 2024. The company serves the healthcare and life sciences markets, although publicly available information provides limited detail about its geographic operations and commercial reach.

View Firefly Neuroscience Profile